Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v22-EN Version v13-EN
Language English English
Date Updated 2019-07-06 2019-05-16
Drug Identification Number 02238617 02238617
Brand name VIRACEPT -250MG VIRACEPT -250MG
Common or Proper name Viracept Viracept
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients NELFINAVIR NELFINAVIR
Strength(s) 250MG 250MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 1x300 BTL 1x300 BTL
ATC code J05AE J05AE
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-05-31 2019-05-21
Actual start date 2019-05-31
Estimated end date 2019-07-05 2019-07-05
Actual end date 2019-07-05
Shortage status Resolved Anticipated shortage
Company comments Distributed by ViiV Healthcare. Distributed by ViiV Healthcare.
Health Canada comments